Not on air · 2 of 3 networks checked
uMotif ads
- umotif.com
- Software Development
- GB
- 101 employees
uMotif’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 22. Watch uMotif on any plan to get each new one in your feed.
Watchlist included in every plan
What uMotif runs
- Single image · LinkedIn
- 5
- Video · LinkedIn
- 1
- Google ads on 13 Oct 2026
- 10
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksNov 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 3 Nov 2026 | See all 22 ads → | ||
| Meta | Not checked | — | |||
| Recently | 10 | Ads on the Google Ads Transparency Center | Checked 13 Oct 2026 | Collect them with the API → |
uMotif has no live LinkedIn ads. We recorded 10 Google ads on 13 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 3 Jun 2026
“Why are #eCOA studies still so challenging?” uMotif Chief Scientific Officer Florence Mowlem, PhD, tackles this question in her latest blog & shows how addressing barriers to success head-on can foster greater collaboration, efficiency & optimization in #clinicaltrials. https://lnkd.in/eQG9tVaZ
- LINKEDIN · IMAGESince 1 Jun 2026
Andrea Valente today assumed the role of uMotif #CEO, stepping up from her previous position as #COO. Andrea’s operational leadership, deep #clinicaltrial technology industry knowledge, and patient- and site-centric focus will continue to expand uMotif’s role as a trusted provider of modern #eCOA and #eConsent solutions. Exciting times ahead for uMotif! Read the announcement: https://lnkd.in/e92MDwWN
- LINKEDIN · IMAGESince 27 May 2026
18 months after the FDA released its guidance on #PatientReportedOutcomes in #oncology #clinicaltrials, uMotif Chief Scientific Officer Florence Mowlem, PhD examines what has changed and why progress on #PROM inclusion remains slower than expected. Read the blog: https://lnkd.in/eenkuKUP
- LINKEDIN · IMAGESince 18 May 2026
Exciting news: uMotif has launched a new offering, Scientific Consulting Services, which will bring deep and broad design capabilities for clinical trials and real-world studies to sponsors and CROs. This is an important extension of uMotif's commitment to eCOA market leadership and user-centric study design. Services span all vital design areas, including protocol input; eCOA strategy, design, and build; eCOA migration and implementation guidance; diary design and development; and eCOA licensing management and translation services. uMotif Chief Scientific Officer Florence Mowlem, PhD will lead the new practice. Learn more: https://lnkd.in/ekpyK7Ab Andrea Valente #eCOA #clinicaltrials #realworldstudies #CROs #clinicaltrialsponsors #eCOAbestpractices
- LINKEDIN · IMAGESince 5 May 2026
uMotif welcomes #eClinical technology industry leader James Thatcher as our new Chief Commercial Officer. James brings a powerful combination of deep industry knowledge, sharp sales acumen, and a collaborative management approach – qualities that will fuel uMotif’s continued growth and market leadership. Read the announcement. https://lnkd.in/eKtN2R_z #eCOA #eConsent #ePRO #clinicaltrials #moversandshakers
- LINKEDIN · VIDEOSince 29 Apr 2026
Trials only succeed when patients stay engaged. See how uMotif’s platform puts the patient first to improve compliance, retention and data quality.
6 of 22 adsSign up to see every uMotif ad, filter by format and date, and get alerts on new ones.
See all 22 adsQuestions about uMotif’s ads
Is uMotif running LinkedIn ads?
We recorded no live LinkedIn ads for uMotif on 7 Nov 2026.
How many LinkedIn ads has uMotif run?
LinkedIn’s ad library lists 22 ads for uMotif. We recorded 22 LinkedIn ads for uMotif, first recorded on 2 Oct 2026 and last recorded on 2 Oct 2026.
Does uMotif run Google ads?
Yes. We recorded 10 Google ads for the domain umotif.com on 13 Oct 2026.
Which ad formats does uMotif use?
The 6 LinkedIn ads on this page include 5 image ads and 1 video ad.
Watch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.